Новый зубной пробиотический эликсир Дентозар и клинико-лабораторная оценка его эффективности
Забокрицкий Николай Александрович, Гайсина Елена Фахаргалеевна · Здоровье и образование в XXI веке · 2014
Designed and proposed for use in dentistry in various inflammatory diseases, in particular, in case of chronic generalized periodontitis, new probiotic metabolic drug Dentozar, possessing high antagonistic activity in relation to conditionally pathogenic microflora of such delivery, as Staphylococcus, Streptococcus, Pseudomonas, Veillonella, Neisseria, Actinomyces, Treponema, Fusobacterium, Proteus, Escherichia, Candida, allowing in short terms to eliminate disbiotical and inflammation in the tissues and organs of the oral cavity. The mechanism of action of the preparation is specific influence of biologically active metabolites, their bacteriostatic, high enzymatic activity, anti-inflammatory activity and stimulation of cell and humoral factors of nonspecific immunity. In result of the implementation of the research showed that significantly decreased the frequency of representatives of the microflora, the most typical of chronic generalized periodontitis moderate severity. Decreased or decreased to physiological values of the concentration of such species of microorganisms: Pseudomonas aeruginosa, Treponema macrodentium, Streptococcus haemolyticus, Streptococcus mutants, Staphylococcus epidermidis, Staphylococcus aureus, Candida albicans, Fusobacterium polymorphum, Neisseria spp., Actinomyces spp. Simultaneously, there is an extremely important fact increase to 80% the number of lactic acid bacteria that are the most important representatives of the normal microflora.
Cited by 0 works.